These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2694383)

  • 1. [Palpitin in disorders of cardiac rhythm].
    Zadionchenko VS; Vladimirova LM; Smirnov VK; Ivashchuk AG; Terekhova TM; Troshina EV; Vladimirov PV; Sliuniastikov MA
    Sov Med; 1989; (10):62-5. PubMed ID: 2694383
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the treatment of cardiac arrhythmias with Palpitin.
    Oźarek-Medyńska T; Krynicki M; Polubiec A
    Ther Hung; 1990; 38(1):26-9. PubMed ID: 2111940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacology of disopyramide].
    Rewerski W; Dorociak A; Walczak F; Dobiasz A
    Pol Tyg Lek; 1980 Jul; 35(29):1109-12. PubMed ID: 7001399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamics and pharmacokinetics of disopyramide phosphate].
    Ol'binskaia LI; Tiukavkina NA; Kuz'mina MM; Beloborodov VL; Klimov AV
    Farmakol Toksikol; 1985; 48(4):73-8. PubMed ID: 3930285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effectiveness of palpitin in treating heart rhythm disorders in ischemic heart disease patients].
    Kurakina TI; Gorshkov VA; Sherashov VS; Solov'eva FV
    Kardiologiia; 1987 May; 27(5):39-41. PubMed ID: 3116314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ectopic ventricular activity with palpitin (disopyramide)].
    Penkov N; Mitkova M; Kaponov Kh; Karastatev D
    Vutr Boles; 1987; 26(2):54-7. PubMed ID: 2440188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical observations on effects of disopyramide on arrhythmias].
    Hu BL; Tao SQ; Liu LS; Chen ZJ; Lu ZL; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():60-2. PubMed ID: 6459881
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of ritmilen in disorders of cardiac rhythm].
    Antiuf'ev VF; Arkhipov MV; Bychkova MA
    Klin Med (Mosk); 1985 Oct; 63(10):84-8. PubMed ID: 3908802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our first clinical test of disopyramide (H 3292) on cardiac rhythm disorders].
    Desruelles J; Gerard A; Ducatillon P; Herbaux A
    Therapie; 1967; 22(4):937-44. PubMed ID: 4863260
    [No Abstract]   [Full Text] [Related]  

  • 12. Examination of the anti-arrhythmic effect of Palpitin (disopyramide).
    Rohla M; Balázsi I
    Ther Hung; 1987; 35(4):196-9. PubMed ID: 3447303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of anti-arrhythmic activity of palpitin and cardio-hemodynamic effects of its administration].
    Kurakina TI; Gorshkov VA; Nesvetov VN
    Kardiologiia; 1990 Jun; 30(6):73-6. PubMed ID: 1699023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    Ee BK; Chia BL; Ng RA; Oh V; Tan AT; Choo M
    Singapore Med J; 1982 Aug; 23(4):185-90. PubMed ID: 7178900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disopyramide in heart arrhythmias].
    Pellegrino L; Di Michele A; Prencipe D
    Boll Soc Ital Cardiol; 1972; 17(8):617-25. PubMed ID: 4655948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of intravenous disopyramide in the treatment of symptomatic refractory ventricular arrhythmia].
    Leone A
    Minerva Cardioangiol; 1984 Mar; 32(3):151-6. PubMed ID: 6728204
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of oral disopyramide on mortality and extension of infarction in cases of acute myocardial infarction admitted to open wards.
    Sharma BD; Chug S; Mathur KP
    J Assoc Physicians India; 1983 Mar; 31(3):149-51. PubMed ID: 6352667
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma concentration of disopyramide given as capsules and controlled release tablets.
    Arnman K; Graffner C; Rikner L; Ryden L; Voog L
    Eur J Clin Pharmacol; 1983; 24(2):199-203. PubMed ID: 6840167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
    Meyers DG; Mohiuddin SM
    Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.